+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07141264

Study of Adebrelimab with Etoposide Capsules as Maintenance Treatment for Extensive-Stage Small Cell Lung Cancer in Adults

Led by Tang-Du Hospital · Updated on 2025-12-30

32

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of combining adebrelimab with etoposide capsules as maintenance therapy for patients with extensive-stage small cell lung cancer ES-SCLC. This is a Phase 2, single-arm clinical study aiming to observe how well this treatment works and monitor any side effects. The study is planned to enroll 32 patients in Shaanxi Province, China, starting in August 2025 and ending by December 2027. Participants will receive treatment cycles lasting 3 weeks each. On the first day of each cycle, adebrelimab is given as an intravenous dose of 1200 mg every 3 weeks. Etoposide capsules are taken orally daily for the first 14 days of each 21-day cycle at doses of 50 mg or 25 mg. Treatment continues until scans confirm tumor progression or other reasons require stopping. Throughout the study, patients will undergo regular assessments to check vital signs, perform physical exams, lab tests, and evaluate their overall health to determine if they can continue treatment. During the study, participants will be closely monitored for side effects and treatment response using imaging and clinical evaluations. The main outcome measured is progression-free survival over up to 2 years. Additional outcomes include overall survival up to 4 years, objective response rate, and duration of response assessed up to 1 year. The estimated treatment period for each patient depends on disease progression and tolerance to therapy, with ongoing follow-up visits to ensure safety and effectiveness.

CONDITIONS

Brief Title

Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy

Research Team

L

Lei Pan, Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here